Welcome to LookChem.com Sign In|Join Free
  • or
3-methyl-4-nitrobenzene-1-sulfonyl chloride is an organic compound with the chemical formula C7H6ClNO4S. It is a derivative of benzene, featuring a methyl group at the 3rd carbon, a nitro group at the 4th carbon, and a sulfonyl chloride group at the 1st carbon. 3-methyl-4-nitrobenzene-1-sulfonyl chloride is known for its reactivity and is often used as a synthetic intermediate in the preparation of various pharmaceuticals, dyes, and other organic compounds. Due to its sulfonyl chloride functionality, it can readily undergo nucleophilic substitution reactions, making it a valuable building block in organic synthesis. The compound is typically synthesized through the chlorosulfonation of 3-methyl-4-nitrobenzene, followed by the displacement of the hydroxyl group with a chloride ion. It is important to handle 3-methyl-4-nitrobenzene-1-sulfonyl chloride with care due to its potential reactivity and the presence of functional groups that can be hazardous under certain conditions.

78726-75-7

Post Buying Request

78726-75-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78726-75-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 78726-75-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,7,2 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 78726-75:
(7*7)+(6*8)+(5*7)+(4*2)+(3*6)+(2*7)+(1*5)=177
177 % 10 = 7
So 78726-75-7 is a valid CAS Registry Number.

78726-75-7Relevant academic research and scientific papers

Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)

-

, (2015/12/25)

The present invention identifies a compound which binds to the PAH1 domain of mSin3B that specifically binds to neural restrictive silencer factor NRSF, and uses the compound as a prophylactic and/or a therapeutic for diseases associated with abnormal expression of neural restrictive silencer factor NRSF/REST or abnormal expression of genes targeted by NRSF/REST, such as Huntington's disease, medulloblastoma and neuropathic pain. The present invention provides a pharmaceutical composition comprising a substance capable of binding to the PAH1 domain of mSin3B, e.g., a compound represented by the following formula (1), a pharmacologically acceptable salt thereof, or a pharmacologically acceptable ester thereof: wherein n represents 0 or 1; R1, R2, R3, R4 and R5 each independently represent a hydrogen atom, a hydrocarbon group or a functional group; Y represents a single bond, a carbonyl group, —CONH—, —NHCO— or a sulfonyl group; and Z represents a nitrogen-containing heterocyclic group which may have a substituent, an amino group which may have a hydrocarbon group or an aromatic hydrocarbon group, or a nitrogen and oxygen-containing heterocyclic group which may have a substituent.

Sulfonyl esters. 2. CS cleavage in some substitution reactions of nitrobenzensulfonates

Baum, James Clayton,Bolhassan, Jimat,Langler, Richard Francis,Pujol, Paul Joseph,Raheja, Raj Kumar

, p. 1450 - 1455 (2007/10/02)

An attempt to explore aromatic sulfonate esters as agents for the condensation of alcohols with mercaptans revealed an unusual process for sulfonate esters: CS bond rupture.Two mechanistic possibilities for CS bond rupture are explored: (i) radical anion intermediacy via singlet electron transfer and (ii) nucleophilic aromatic substitution.Both experiments and molecular orbital computations are presented to support the conclusion that nucleophilic aromatic substitutions are occuring.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 78726-75-7